Skip to main content

ADC Therapeutics SA (ADCT)

NYSE: ADCT · IEX Real-Time Price · USD
1.66
+0.07 (4.40%)
Dec 29, 2023, 4:00 PM EST - Market closed

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $122.57M in the twelve months ending September 30, 2023, down -21.99% year-over-year. Revenue in the quarter ending September 30, 2023 was $14.49M, a -81.01% decrease year-over-year. In the year 2022, ADC Therapeutics had annual revenue of $209.91M with 518.89% growth.

Revenue (ttm)
$122.57M
Revenue Growth
-21.99%
P/S Ratio
1.21
Revenue / Employee
$386,644
Employees
317
Market Cap
147.81M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022209.91M175.99M
518.89%
Dec 31, 202133.92M--
Dec 31, 20200--
Dec 31, 20192.34M1.20M
105.26%
Dec 31, 20181.14M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Oncology Institute 309.88M
Xtant Medical Holdings 78.46M
Alpha Teknova 36.71M
bluebird bio 21.73M
Capricor Therapeutics 14.05M
Safety Shot 4.88M
Revenue Rankings

ADCT News

More News